CIK: 0001534261
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | WGS | Genedx Holdings CORP | Stock-Other | 24.29% | -9.67% | — | |
| 2 | RVMD | Revolution Medicines INC | Stock-Healthcare | 12.75% | +6.23% | -2.64% | |
| 3 | BLFS | Biolife Solutions INC | Stock-Other | 8.95% | -0.34% | -11.18% | |
| 4 | LAB | Standard Biotools INC | Stock-Other | 7.06% | -0.88% | +14.47% | |
| 5 | RLAY | Relay Therapeutics INC | Stock-Other | 6.83% | +4.03% | +14.66% | |
| 6 | GPCR | Structure Therapeutics INC | Stock-Other | 5.08% | -0.79% | -24.44% | |
| 7 | ILMN | Illumina INC | Stock-Healthcare | 4.89% | +0.06% | +14.29% | |
| 8 | RNAGBP | Avidity Biosciences INC | Stock-Other | 4.48% | -4.48% | EXIT | |
| 9 | BEAM | Beam Therapeutics INC | Stock-Other | 2.75% | -0.31% | — | |
| 10 | GH | Guardant Health INC | Stock-Healthcare | 2.41% | -0.21% | +280.00% | |
| 11 | MAZE | Maze Therapeutics INC | Stock-Other | 1.95% | -0.23% | — | |
| 12 | DNLI | Denali Therapeutics INC | Stock-Other | 1.89% | +0.79% | +106.74% | |
| 13 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.85% | +0.03% | +36.36% | |
| 14 | NGNE | Neurogene INC | Stock-Other | 1.66% | +0.51% | — | |
| 15 | TXG | 10x Genomics Inc-class A | Stock-Other | 1.42% | +2.24% | — | |
| 16 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 1.16% | -1.16% | EXIT | |
| 17 | TEM | Tempus Ai Inc-cl A | Stock-Healthcare | 1.08% | -0.07% | — | |
| 18 | UNH | Unitedhealth Group INC | Stock-Healthcare | 1.03% | -1.03% | EXIT | |
| 19 | SEPN | Septerna INC | Stock-Other | 0.96% | +0.05% | — | |
| 20 | HIMS | Hims & Hers Health INC | Stock-Healthcare | 0.78% | +0.32% | +67.39% | |
| 21 | VCYT | Veracyte INC | Stock-Other | 0.72% | -0.05% | — | |
| 22 | DXCM | Dexcom INC | Stock-Healthcare | 0.72% | -0.72% | EXIT | |
| 23 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.71% | +0.59% | — | |
| 24 | CI | THE Cigna Group | Stock-Healthcare | 0.68% | -0.68% | EXIT | |
| 25 | PRME | Prime Medicine INC | Stock-Other | 0.68% | +0.15% | — | |
| 26 | INCY | Incyte CORP | Stock-Healthcare | 0.61% | -0.61% | EXIT | |
| 27 | DGX | Quest Diagnostics INC | Stock-Healthcare | 0.54% | +0.20% | — | |
| 28 | TSHA | Taysha Gene Therapies INC | Stock-Other | 0.51% | +0.59% | — | |
| 29 | PACB | Pacific Biosciences Of Calif | Stock-Other | 0.49% | -0.42% | +483.58% | |
| 30 | LEGN | Legend Biotech Corp-adr | Stock-Other | 0.29% | -0.29% | EXIT | |
| 31 | BBOT | Bridgebio Oncology Therapeut | Stock-Other | 0.22% | -0.03% | — | |
| 32 | ABSI | Absci CORP | Stock-Other | 0.21% | +0.01% | — | |
| 33 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 0.11% | +0.04% | — | |
| 34 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 0.08% | +0.15% | — | |
| 35 | IPSC | Century Therapeutics INC | Stock-Other | 0.08% | +0.13% | — | |
| 36 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 0.04% | — | — | |
| 37 | DNA | Ginkgo Bioworks Holdings INC | Stock-Other | 0.02% | — | — | |
| 38 | TNYA | Tenaya Therapeutics INC | Stock-Other | 0.02% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | +2.4% | -2.64% | Trim |
| 2 | RLAY | Relay Therapeutics INC | +1.9% | +14.66% | Add |
| 3 | GH | Guardant Health INC | +1.9% | +280.00% | Add |
| 4 | GPCR | Structure Therapeutics INC | +1.5% | -24.44% | Trim |
| 5 | DNLI | Denali Therapeutics INC | +0.8% | +106.74% | Add |
| 6 | ILMN | Illumina INC | +0.7% | +14.29% | Add |
| 7 | PACB | Pacific Biosciences Of Calif | +0.4% | +483.58% | Add |
| 8 | MAZE | Maze Therapeutics INC | +0.3% | — | Unchanged |
| 9 | UNH | Unitedhealth Group INC | +0.3% | +100.00% | Add |
| 10 | SEPN | Septerna INC | +0.1% | — | Unchanged |
| 11 | GLUE | Monte Rosa Therapeutics INC | 0% | — | Unchanged |
| 12 | IPSC | Century Therapeutics INC | 0% | — | Unchanged |
| 13 | DNA | Ginkgo Bioworks Holdings INC | 0% | — | Unchanged |
| 14 | TNYA | Tenaya Therapeutics INC | 0% | — | Unchanged |
| 15 | RXRX | Recursion Pharmaceuticals-a | 0% | — | Unchanged |
| 16 | ABSI | Absci CORP | 0% | — | Unchanged |
| 17 | CTNM | Contineum Therapeutics Inc-a | 0% | — | Unchanged |
| 18 | BBOT | Bridgebio Oncology Therapeut | -0.1% | — | Unchanged |
| 19 | VCYT | Veracyte INC | -0.1% | — | Unchanged |
| 20 | INCY | Incyte CORP | -0.1% | — | Unchanged |
| 21 | SPRY | Ars Pharmaceuticals INC | -0.2% | — | Unchanged |
| 22 | NGNE | Neurogene INC | -0.2% | — | Unchanged |
| 23 | ALNY | Alnylam Pharmaceuticals INC | -0.2% | +36.36% | Add |
| 24 | HIMS | Hims & Hers Health INC | -0.3% | +67.39% | Add |
| 25 | BEAM | Beam Therapeutics INC | -0.5% | — | Unchanged |
| 26 | PRME | Prime Medicine INC | -0.8% | — | Unchanged |
| 27 | TEM | Tempus Ai Inc-cl A | -0.9% | — | Unchanged |
| 28 | LAB | Standard Biotools INC | -1.4% | +14.47% | Add |
| 29 | RNAGBP | Avidity Biosciences INC | -2% | -43.82% | Trim |
| 30 | WGS | Genedx Holdings CORP | -2.7% | — | Unchanged |
| 31 | BLFS | Biolife Solutions INC | -5.3% | -11.18% | Trim |
| 32 | TXG | 10x Genomics Inc-class A | — | NEW | New buy |
| 33 | DXCM | Dexcom INC | — | NEW | New buy |
| 34 | SRRK | Scholar Rock Holding CORP | — | NEW | New buy |
| 35 | CI | THE Cigna Group | — | NEW | New buy |
| 36 | DGX | Quest Diagnostics INC | — | NEW | New buy |
| 37 | TSHA | Taysha Gene Therapies INC | — | NEW | New buy |
| 38 | EXK | Exact Sciences CORP | — | EXIT | Sold out |
| 39 | LEGN | Legend Biotech Corp-adr | — | NEW | New buy |